ENTITY

Opthea Ltd (OPT AU)

Analysis

Health Care • Australia

Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.

Refresh

Exchange Announcement • 15 Nov 2024 09:57

Initial Director's Interest Notice

Exchange Announcement • 15 Nov 2024 07:24

Opthea Received A$15.9 Million R&D Tax Incentive

Exchange Announcement • 15 Nov 2024 07:22

Results of Meeting

Exchange Announcement • 15 Nov 2024 06:37

Director Appointment/Resignation

Exchange Announcement • 15 Nov 2024 06:34

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Initial Director's Interest Notice

Opthea Received A$15.9 Million R&D Tax Incentive

Results of Meeting

Director Appointment/Resignation

Chair's Address to Shareholders